1. Home
  2. PAHC vs EOS Comparison

PAHC vs EOS Comparison

Compare PAHC & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • EOS
  • Stock Information
  • Founded
  • PAHC 1946
  • EOS 2005
  • Country
  • PAHC United States
  • EOS United States
  • Employees
  • PAHC N/A
  • EOS N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • EOS Trusts Except Educational Religious and Charitable
  • Sector
  • PAHC Health Care
  • EOS Finance
  • Exchange
  • PAHC Nasdaq
  • EOS Nasdaq
  • Market Cap
  • PAHC 1.6B
  • EOS 1.3B
  • IPO Year
  • PAHC 2014
  • EOS N/A
  • Fundamental
  • Price
  • PAHC $37.11
  • EOS $24.18
  • Analyst Decision
  • PAHC Hold
  • EOS
  • Analyst Count
  • PAHC 4
  • EOS 0
  • Target Price
  • PAHC $27.50
  • EOS N/A
  • AVG Volume (30 Days)
  • PAHC 280.5K
  • EOS 84.1K
  • Earning Date
  • PAHC 11-05-2025
  • EOS 01-01-0001
  • Dividend Yield
  • PAHC 1.29%
  • EOS 6.80%
  • EPS Growth
  • PAHC 1895.04
  • EOS N/A
  • EPS
  • PAHC 1.19
  • EOS N/A
  • Revenue
  • PAHC $1,296,215,000.00
  • EOS N/A
  • Revenue This Year
  • PAHC $14.80
  • EOS N/A
  • Revenue Next Year
  • PAHC $3.16
  • EOS N/A
  • P/E Ratio
  • PAHC $31.18
  • EOS N/A
  • Revenue Growth
  • PAHC 27.37
  • EOS N/A
  • 52 Week Low
  • PAHC $16.16
  • EOS $15.62
  • 52 Week High
  • PAHC $41.57
  • EOS $20.63
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 52.45
  • EOS 51.27
  • Support Level
  • PAHC $36.82
  • EOS $23.66
  • Resistance Level
  • PAHC $41.36
  • EOS $24.21
  • Average True Range (ATR)
  • PAHC 1.24
  • EOS 0.26
  • MACD
  • PAHC -0.55
  • EOS -0.00
  • Stochastic Oscillator
  • PAHC 18.61
  • EOS 54.27

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About EOS Eaton Vance Enhance Equity Income Fund II

Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.

Share on Social Networks: